Company ViaDerma, Inc. Other OTC
Equities
VDRM
US92555K1016
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Topical Antibiotic
100.0
%
| 1 | 100.0 % | 1 | 100.0 % | +11.07% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 1 | 100.0 % | 1 | 100.0 % | +11.07% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chris Ayo Otiko
CEO | Chief Executive Officer | - | 14-03-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chris Ayo Otiko
CEO | Chief Executive Officer | - | 14-03-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,228,143,498 | 1,215,862,063 ( 99.00 %) | 0 | 99.00 % |
Company contact information
ViaDerma, Inc.
4640 Admiralty Way Suite 500
90292, Marina Del Rey
+
Sector
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.75B | |
+48.15% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |